Jan Hirsch

picture of Jan  Hirsch

Director and Founding Dean
Pharmaceutical Sciences

B.S. Pharm, University of South Carolina, College of Pharmacy, Pharmacy
M.S., University of South Carolina, College of Pharmacy, Pharmacy Administration
Ph.D., University of South Carolina, College of Pharmacy, Pharmacy Administration

Phone: (949) 824-0505
Email: jdhirsch@uci.edu

University of California, Irvine
101 Theory, Suite 100
Mail Code: 3958
Irvine, CA 92697
Academic Distinctions
Excellence in Teaching Award, UCSD (2004)
Distinguished Alumni Award, University of South Carolina College of Pharmacy (2002)
Outstanding Young Women of America (1984).
Research Abstract
Dr. Hirsch's research interests are focused in the areas of pharmacoeconomics and outcomes research. Specifically, i) assessing the full value (economic, clinical and humanistic) of pharmacy services and pharmaceuticals in clinical trials or observational studies across therapeutic areas and ii) integrating patient reported outcomes (PRO's) (e.g. burden elements, Health Related Quality of Life (HRQOL), satisfaction) into pharmaceutical and medical practice to improve patient management.

Dr. Hirsch has been the Principal Investigator (P.I.) for sequential studies which resulted in the creation and validation of a disease-specific instrument to assess the impact of gout symptoms on patient HRQOL; the Gout Impact Scale (GIS). The GIS is an important contribution to clinical practice and research since the prevalence of gout is increasing and assessment of HRQOL using a disease specific instrument is prevalent for other diseases within rheumatology (e.g. arthritis), but no such instrument existed for gout - until the GIS.

She has also served as PI or Co-PI for several studies evaluating the clinical, economic and humanistic outcomes for patients receiving novel pharmacy services; hypertension, mental health, diabetes, HIV/AIDS, and immunizations. She was PI for a NIH funded project examining the comparative effectiveness of pharmacist-provided medication therapy management (MTM) services within medical group practices.
Hirsch et al (2014). Primary Care-based, Pharmacist -physician Collaborative Medication-therapy Management of Hypertension: A Randomized, Pragmatic Trial. Clinical Therapeutics. 36:1244-54

Hirsch et al (2014). Validation of a Patient Level Medication Regimen Complexity Index as a Possible Tool to Identify Patients for Medication Therapy Management Intervention. Pharmacotherapy. 34:826- 35.

Hirsch et al (2014). Efficacy of Canakinumab vs. triamcinolone acetonide according to multiple gouty arthritis-related health outcomes measures. International Journal of Clinical Practice. 68(12): 1503-1507

Hirsch et al (2017) Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic. J Manag Care Spec Pharm. (3): 318-326
Last updated